TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1

Table 2 Correlation of TRIM6 expression in colorectal cancer tissues with different clinicopathological features (n = 90)

Characteristic	TRIM6		P-value
Characteristic	Low (n = 34)	High (n = 56)	P-value
Gender
Male	17	31	0.6671
Female	17	25	0.6671
Age (years)
≥ 65	12	17	0.6671
< 65	22	39	0.6671
Tumor size (cm)
< 4.0	18	12	0.0029**
≥ 4.0	16	44
Pathologic differentiation
Well/Moderate	30	45	0.3943
Poor	4	11	0.3943
Clinical stage
I/II	22	21	0.0167*
III	12	35	0.0167*
Metastasis
no	27	46	0.7857
yes	7	10	0.7857
Vital status (at followed-up)
Alive	23	19	0.0024**
Dead	11	37	0.0024**
CEA levels (ng/mL)
< 3.5	18	14	0.0119*
≥ 3.5	16	42	0.0119*

Clinicopathological features were assessed using the Fisher’s exact test. *P < 0.05, **P < 0.01

ISSN: 1756-9966